Skip to main content

News

July 23, 2025

bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies

bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this partnership is helping accelerate the development of individualized cancer treatments.
Discover More

  • February 27, 2023

    2022: a fruitful year of CSR achievements

    We are committed to play our part and as every gesture counts to change the game, we have implemented a number of concrete actions in line with our CSR objectives.
    Read more

  • August 02, 2022

    Our EcoVadis Score Increases by 3 Points This Year !

    For the third consecutive year, we are awarded a Platinum medal, the highest level distinguishing bioMérieux as part of the Top 1%.
    Read more

  • July 29, 2022

    CO2 emissions: bioMérieux is switching to renewable energy

    Doing our part to help reduce CO2 emissions through renewable energy.
    Read more

  • July 01, 2022

    11 of Our Best Channel Partners Invited in Lyon, France

    We were very happy to have rewarded 11 of our most performing Channel Partners with a week in Marcy l'Etoile, France, in our HQ.
    Read more